Arkansas Cannabis Ballot Measures: History, Laws, and Voter Initiatives

Executive Summary

Arkansas has become a pivotal battleground for cannabis reform through the ballot initiative process, with voters weighing multiple legalization measures since 2012. The state's journey toward cannabis policy reform has been marked by narrow defeats, legislative resistance, and ongoing legal challenges to ballot access requirements. In August 2026, a federal judge struck down key provisions of Arkansas's ballot initiative laws as unconstitutional, ruling that signature-gathering restrictions represented some of the "most egregious" barriers to direct democracy in the nation. This decision came after years of failed legalization attempts, including a 2022 recreational cannabis measure that fell short despite collecting over 190,000 signatures. Arkansas currently operates a limited medical marijuana program established by voters in 2016, but adult-use legalization remains elusive. The legal landscape surrounding ballot measures directly impacts whether cannabis reform advocates can place future initiatives before voters, making Arkansas a critical test case for direct democracy and drug policy reform across conservative Southern states.

Why This Matters

Arkansas's ballot measure battles affect more than 3 million residents and represent a broader struggle over direct democracy in states where legislatures resist cannabis reform. The state's medical marijuana program serves approximately 85,000 registered patients as of 2026, generating over $350 million in annual sales across 38 licensed dispensaries. These patients depend on continued access to cannabis for conditions including chronic pain, PTSD, cancer, and epilepsy. The constitutional challenge to Arkansas's ballot initiative laws has national implications. If restrictive signature-gathering requirements stand, similar barriers could spread to other states where citizen-led initiatives represent the only viable path to cannabis legalization. Conversely, successful legal challenges could open pathways for reform in conservative states where legislatures refuse to act. For the cannabis industry, Arkansas represents a $500 million potential adult-use market based on population and consumption patterns in comparable states. Multi-state operators including Acreage Holdings, Green Thumb Industries, and Curaleaf have established medical operations in Arkansas, positioning themselves for potential adult-use expansion. The outcome of ballot measure litigation directly affects capital allocation decisions, real estate investments, and employment for thousands of Arkansans in cultivation, processing, retail, and ancillary businesses. Advocacy organizations including Arkansans for Cannabis Reform, the Drug Policy Alliance, and the Marijuana Policy Project have invested millions in signature-gathering campaigns, making ballot access rules a matter of organizational survival and strategic resource allocation.

Background and History

Early Medical Marijuana Attempts (2012)

Arkansas voters first considered cannabis legalization in November 2012 when the Arkansas Medical Marijuana Act appeared on the ballot as Issue 5. The measure would have allowed patients with qualifying conditions to possess up to 2.5 ounces of cannabis and established a system of nonprofit dispensaries. The initiative collected over 62,000 signatures to qualify for the ballot, surpassing the then-required threshold. Issue 5 narrowly failed with 48.56% voting in favor and 51.44% opposed—a margin of just 29,000 votes out of nearly 1 million cast. The measure performed strongest in urban counties including Pulaski County (Little Rock) and Faulkner County, while rural counties in the Arkansas Delta and northwestern regions voted against it. Opponents including the Arkansas Family Council and Keep Arkansas Safe raised concerns about federal-state conflicts and impaired driving.

The 2016 Medical Marijuana Victory

Four years later, Arkansas voters approved Amendment 98 to the state constitution in November 2016, establishing the state's current medical marijuana program. The measure passed with 53.2% support, making Arkansas the first Southern state to approve medical cannabis through a ballot initiative. Amendment 98, officially titled the Arkansas Medical Marijuana Amendment, authorized the Arkansas Department of Health to license up to 40 dispensaries and eight cultivation facilities. The campaign, led by Arkansans for Compassionate Care, raised over $2.1 million and emphasized patient testimonials from veterans with PTSD, children with epilepsy, and cancer patients. The measure specified 18 qualifying conditions and established a registry identification card system. Patients or designated caregivers could possess up to 2.5 ounces of usable cannabis every 14 days. A competing measure, Issue 7, also appeared on the 2016 ballot but failed with only 47.4% support. Issue 7 would have created a more restrictive program with tighter cultivation controls and no dispensary system, instead allowing patients to grow their own cannabis. The presence of two competing measures created voter confusion but ultimately the more comprehensive Amendment 98 prevailed.

Implementation Challenges (2017-2019)

The Arkansas Medical Marijuana Commission faced significant delays implementing the voter-approved program between 2017 and 2019. The Commission received 227 applications for the eight cultivation licenses and 354 applications for 40 dispensary licenses. The scoring and selection process became mired in litigation, with unsuccessful applicants filing multiple lawsuits alleging scoring irregularities and conflicts of interest. The first dispensaries did not open until May 2019—more than two years after voters approved the program. Green Springs Medical in Hot Springs became the first licensed dispensary to commence sales on May 10, 2019. By the end of 2019, only 18 of the authorized 40 dispensaries had opened, and only five of eight cultivation facilities were operational. The Arkansas General Assembly attempted to modify the voter-approved program through legislation in 2017 and 2019, passing bills to restrict dispensary locations, limit advertising, and impose additional regulatory requirements. Governor Asa Hutchinson, who opposed Amendment 98 during the campaign, signed several of these restrictions into law while vetoing others he deemed unconstitutional modifications of a voter-approved amendment.

Adult-Use Legalization Attempts (2020-2022)

Advocates launched campaigns for adult-use legalization beginning in 2020, but faced mounting procedural obstacles. In 2020, a coalition called Responsible Growth Arkansas began collecting signatures for a constitutional amendment to legalize recreational cannabis for adults 21 and older. The COVID-19 pandemic severely hampered signature-gathering efforts, and the campaign suspended operations in August 2020 after collecting approximately 89,000 signatures—short of the required threshold. In 2022, multiple groups attempted to place adult-use measures on the November ballot. Responsible Growth Arkansas, backed by existing medical marijuana license holders, submitted over 192,000 signatures for a constitutional amendment in July 2022. The measure would have legalized possession of up to one ounce for adults, established a regulatory framework for adult-use sales, and allocated tax revenue to workforce training programs and law enforcement. The Arkansas Supreme Court removed the measure from the ballot in August 2022, ruling that the ballot title was insufficient and misleading. In a 5-2 decision, the court found that the 24-word ballot title failed to adequately inform voters of the amendment's scope and effects, particularly regarding the relationship between the new adult-use program and the existing medical program. The decision came despite the measure having already qualified with sufficient signatures. A separate initiative, Arkansas Adult Use Cannabis Amendment, sponsored by Arkansas True Grass, also collected signatures in 2022 but withdrew before submitting them, citing the unfavorable legal environment and restrictive ballot title requirements.

Legislative Restrictions on Ballot Initiatives (2019-2024)

The Arkansas legislature enacted increasingly restrictive ballot initiative requirements between 2019 and 2024, directly responding to cannabis legalization efforts. In 2019, the legislature passed Act 376, which required petition canvassers to register with the Secretary of State, undergo background checks, and wear identification badges. The law also imposed a 30-day residency requirement for paid canvassers. In 2021, the legislature enacted Act 307 and Act 376, which together required initiative sponsors to collect signatures from at least 50 of Arkansas's 75 counties, with each county's signature total proportional to votes cast in the most recent gubernatorial election. Previously, sponsors could collect signatures statewide without county-specific distribution requirements. The laws also shortened the signature-gathering window and imposed stricter notarization requirements for petition pages. In 2023, Senate Bill 524 further tightened requirements by mandating that signature gatherers submit to fingerprinting and prohibiting anyone with certain criminal convictions from serving as a canvasser. The bill also required sponsors to submit detailed financial disclosures identifying all donors contributing more than $500 to signature-gathering efforts before beginning canvassing. Legislators explicitly cited cannabis legalization efforts when debating these bills. State Senator Bart Hester stated during floor debate on the 2021 measures that "we need to make it harder for out-of-state marijuana interests to buy their way onto our ballot." The cumulative effect of these laws made Arkansas's ballot initiative process among the most restrictive in the nation.

Federal Court Challenge (2024-2026)

In March 2024, Arkansans for Cannabis Reform and individual plaintiffs filed a federal lawsuit challenging the constitutionality of Arkansas's ballot initiative restrictions. The complaint, filed in the U.S. District Court for the Eastern District of Arkansas, alleged that the signature distribution requirements, canvasser restrictions, and shortened timelines violated the First Amendment right to political speech and the Fourteenth Amendment guarantee of equal protection. The plaintiffs argued that the county-specific signature distribution requirement was particularly burdensome, noting that some rural counties had populations under 5,000, making it nearly impossible to collect the proportional number of signatures required. The lawsuit cited expert testimony that the combined restrictions increased the cost of qualifying a ballot measure from approximately $400,000 in 2016 to over $2.5 million in 2024. On August 21, 2026, U.S. District Judge James Moody Jr. issued a preliminary injunction blocking enforcement of key provisions of the ballot initiative laws. In a 78-page opinion, Judge Moody wrote that Arkansas had imposed "some of the most egregious restrictions on direct democracy in the nation" and that the county distribution requirement "serves no legitimate state interest while imposing severe burdens on core political speech." The court found that the restrictions likely violated the First Amendment and ordered Arkansas to revert to pre-2021 signature-gathering rules for the 2026 election cycle.

Key Players

Arkansans for Cannabis Reform

Arkansans for Cannabis Reform emerged as the leading advocacy organization pushing for adult-use legalization through ballot initiatives. Founded in 2021, the organization is a coalition of patient advocates, criminal justice reform activists, and cannabis industry stakeholders. The group led the 2022 signature-gathering campaign that collected over 192,000 signatures before the Arkansas Supreme Court removed the measure from the ballot. Executive Director Melissa Fults, a medical marijuana patient and longtime reform advocate, has been the public face of the organization. The group served as lead plaintiff in the 2024 federal lawsuit challenging ballot initiative restrictions.

Responsible Growth Arkansas

Responsible Growth Arkansas represents existing medical marijuana license holders and has sponsored multiple legalization initiatives. The organization includes executives from Arkansas's licensed cultivation facilities and dispensaries, who view adult-use legalization as a natural expansion of the existing regulated market. Critics, including some patient advocates, have accused the group of crafting initiatives that favor existing license holders over new market entrants. The organization's 2022 measure included provisions limiting the number of new adult-use licenses and giving preference to existing medical operators.

Arkansas Department of Health

The Arkansas Department of Health administers the state's medical marijuana program under Amendment 98. The department maintains the patient registry, processes applications for registry identification cards, and oversees compliance with possession limits and qualifying conditions. As of August 2026, the department reported 84,731 active registered patients and 38 operational dispensaries. The department has taken a neutral public position on adult-use legalization efforts but has provided fiscal impact analyses to the legislature regarding potential ballot measures.

Arkansas Medical Marijuana Commission

The five-member Arkansas Medical Marijuana Commission licenses and regulates cultivation facilities and dispensaries. Established by Amendment 98, the Commission faced significant controversy during the initial licensing process in 2017-2018. The Commission includes appointees from the Governor, the Speaker of the House, and the Senate President Pro Tempore. Current Chair Dr. Ronda Henry-Tillman has emphasized the Commission's focus on patient safety and regulatory compliance. The Commission has not taken a public position on adult-use legalization but would likely play a regulatory role if voters approve such a measure.

Keep Arkansas Safe

Keep Arkansas Safe is the primary opposition organization fighting cannabis legalization ballot measures. The group is a coalition of law enforcement organizations, faith-based groups, and business associations. Jerry Cox, president of the Arkansas Family Council, serves as the organization's spokesperson. Keep Arkansas Safe opposed the 2012 and 2016 medical marijuana measures and has organized opposition to every subsequent legalization effort. The group argues that legalization would increase impaired driving, youth access, and workplace safety issues. In 2022, Keep Arkansas Safe raised over $800,000 to oppose the adult-use measure before the Arkansas Supreme Court removed it from the ballot.

Arkansas Attorney General Tim Griffin

Arkansas Attorney General Tim Griffin has played a central role in reviewing and approving ballot titles for cannabis initiatives. Under Arkansas law, the Attorney General must certify that a proposed ballot title is clear, accurate, and not misleading before signature gathering can begin. Griffin, who took office in January 2023, rejected multiple cannabis legalization ballot titles in 2023 and 2024, citing concerns about clarity and completeness. His office is defending the state's ballot initiative restrictions in the federal lawsuit, arguing that the requirements serve legitimate state interests in preventing fraud and ensuring geographic diversity in support for constitutional amendments.

Arkansas Supreme Court

The Arkansas Supreme Court has issued multiple rulings affecting cannabis ballot measures, most notably removing the 2022 adult-use initiative from the ballot. The seven-member court has jurisdiction over challenges to ballot titles and the sufficiency of initiative petitions. In the 2022 case Arkansas Medical Marijuana Amendment of 2022 v. Thurston, the court's 5-2 majority found that the ballot title failed to adequately inform voters, despite acknowledging that the underlying amendment text was constitutional. Chief Justice Dan Kemp wrote the majority opinion, while Justices Courtney Rae Hudson and Shawn A. Womack dissented, arguing that the court was improperly substituting its judgment for that of voters.

Legal and Regulatory Framework

Arkansas Constitution Article 5, Section 1

The Arkansas Constitution grants citizens the power to propose constitutional amendments through the initiative process, but with significant procedural requirements. Article 5, Section 1 requires initiative sponsors to collect signatures equal to 10% of votes cast for governor in the most recent election. For the 2026 election cycle, this threshold is approximately 90,000 signatures. The provision also requires that signatures be submitted at least four months before the election and that the Secretary of State verify the signatures within 30 days. Constitutional amendments require a simple majority of votes cast to be adopted. Once approved, amendments can only be modified or repealed by subsequent constitutional amendment—the legislature cannot alter voter-approved constitutional provisions through statute. This constitutional protection is why cannabis reform advocates have pursued amendments rather than statutory initiatives.

Arkansas Code Annotated § 7-9-601 et seq.

Arkansas Code Annotated § 7-9-601 through § 7-9-614 governs the ballot initiative process and has been repeatedly amended to add restrictions. Section 7-9-601 defines key terms including "sponsor," "canvasser," and "petition." Section 7-9-607, as amended in 2021, imposes the county distribution requirement, mandating that signatures come from at least 50 counties with each county contributing a proportional share based on gubernatorial election turnout. Section 7-9-608 establishes canvasser registration requirements, including background checks and identification badge requirements added in 2019. Section 7-9-609 requires sponsors to submit detailed financial disclosures before beginning signature gathering, including identification of all donors contributing over $500. Section 7-9-610 shortens the signature-gathering window and imposes strict notarization requirements for each petition page. These statutory provisions were the primary target of the 2024 federal lawsuit, with plaintiffs arguing that the cumulative burden of the requirements violated constitutional protections for political speech and petition rights.

Amendment 98 (Arkansas Medical Marijuana Amendment)

Amendment 98 to the Arkansas Constitution, approved by voters in 2016, establishes the legal framework for the state's medical marijuana program. The amendment authorizes the Arkansas Department of Health to issue registry identification cards to qualifying patients and designates 18 qualifying medical conditions including cancer, glaucoma, HIV/AIDS, hepatitis C, ALS, Crohn's disease, ulcerative colitis, PTSD, severe arthritis, fibromyalgia, and Alzheimer's disease. Amendment 98 limits patients to possessing 2.5 ounces of usable cannabis every 14 days and prohibits home cultivation. The amendment caps the number of dispensaries at 40 and cultivation facilities at eight, with geographic distribution requirements to ensure access across the state. The amendment provides legal protection for patients, caregivers, and licensed businesses from state prosecution but does not affect federal law. Amendment 98 allocates licensing fees and a 4% privilege tax on dispensary sales to fund program administration, with excess revenue directed to vocational-technical education. The amendment explicitly prohibits public consumption, driving under the influence, and possession on school grounds or in correctional facilities.

Federal Law: Controlled Substances Act

Cannabis remains a Schedule I controlled substance under the federal Controlled Substances Act, 21 U.S.C. § 812, creating ongoing legal conflicts with state programs. The CSA classifies Schedule I substances as having no accepted medical use and a high potential for abuse. Federal law prohibits manufacturing, distributing, dispensing, or possessing cannabis, with penalties including imprisonment and asset forfeiture. The Rohrabacher-Farr Amendment (now Rohrabacher-Blumenauer), attached annually to federal appropriations bills since 2014, prohibits the Department of Justice from using federal funds to prevent states from implementing medical marijuana laws. However, this protection does not extend to adult-use programs and must be renewed annually. The amendment has provided practical protection for Arkansas's medical marijuana program but does not create a permanent safe harbor. The 2018 Farm Bill, 7 U.S.C. § 1639o et seq., legalized hemp containing less than 0.3% delta-9 THC, creating a parallel legal market for CBD and hemp-derived products. Arkansas has implemented hemp regulations under this federal framework, but the relationship between hemp and marijuana programs remains legally complex.

State-by-State Context

Arkansas

Arkansas operates a constitutional medical marijuana program serving over 84,000 patients through 38 dispensaries and eight cultivation facilities. Patients with qualifying conditions can possess up to 2.5 ounces every 14 days. Registry cards cost $50 annually, with reduced fees for veterans and Medicaid recipients. Adult-use cannabis remains illegal, with possession of less than four ounces classified as a Class A misdemeanor punishable by up to one year in jail and a $2,500 fine. The state collected $32.4 million in medical marijuana taxes in fiscal year 2025.

Oklahoma

Oklahoma, Arkansas's western neighbor, approved medical marijuana in 2018 and operates one of the nation's most permissive programs. Oklahoma has no cap on dispensary licenses and allows home cultivation, resulting in over 2,000 licensed dispensaries serving a population of 4 million—a per-capita dispensary rate far exceeding Colorado or California. Oklahoma voters rejected adult-use legalization in March 2023 by a 62-38% margin, demonstrating that even permissive medical programs do not guarantee adult-use approval. Oklahoma's experience has influenced Arkansas policy debates, with opponents citing Oklahoma's market saturation as a cautionary tale.

Missouri

Missouri, Arkansas's northern neighbor, approved adult-use legalization in November 2022 with 53.1% support. Amendment 3 to the Missouri Constitution legalized possession of up to three ounces for adults 21 and older and established a regulated retail market. Missouri's medical program, approved in 2018, provided the infrastructure for adult-use implementation. Adult-use sales began in February 2023, generating over $1.1 billion in first-year revenue. Missouri's success has energized Arkansas reform advocates while demonstrating that conservative Midwestern states can approve adult-use measures through ballot initiatives.

Mississippi

Mississippi voters approved medical marijuana in November 2020 with 74% support, but the state Supreme Court invalidated the measure on procedural grounds in May 2021. The court ruled that Mississippi's initiative process violated the state constitution because it required signatures from five congressional districts, but Mississippi had only four districts following the 2000 census. The legislature subsequently passed a medical marijuana law in 2022, establishing a program that began operations in 2023. Mississippi's experience illustrates the vulnerability of ballot initiatives to procedural challenges and the importance of constitutional compliance.

Louisiana

Louisiana, Arkansas's southern neighbor, operates a limited medical marijuana program established by the legislature in 2015 and expanded in 2019. Louisiana allows medical marijuana for any condition a physician deems debilitating, but the program is limited to two licensed growers and a restricted number of pharmacy dispensaries. Louisiana has not pursued adult-use legalization and does not have a ballot initiative process, requiring all cannabis policy changes to pass through the legislature. The absence of direct democracy in Louisiana highlights the importance of ballot initiatives in Arkansas.

Market and Business Implications

Current Medical Marijuana Market

Arkansas's medical marijuana market generated $353 million in sales in 2025, with 38 operational dispensaries and eight cultivation facilities. The market has grown steadily since the first dispensaries opened in 2019, with monthly sales averaging $29.4 million in 2025. The state's 4% privilege tax on dispensary sales generated $14.1 million in revenue in 2025, funding program administration and vocational-technical education. Wholesale cannabis prices in Arkansas averaged $2,800 per pound for flower in mid-2026, according to industry sources. Dispensary retail prices range from $35-60 per eighth ounce ($280-480 per ounce) depending on quality and THC content. Popular strains in Arkansas dispensaries include Northern Lights, OG Kush, Wedding Cake, and Granddaddy Purple, with patients increasingly seeking high-CBD strains for daytime use. The limited license structure has created significant enterprise value for existing operators. Cultivation licenses have traded privately for $8-15 million, while dispensary licenses have sold for $2-5 million depending on location. Multi-state operators including Acreage Holdings, Green Thumb Industries, and Curaleaf have acquired Arkansas licenses through merger and acquisition activity.

Potential Adult-Use Market

Industry analysts project that adult-use legalization could create a $450-550 million annual market in Arkansas within three years of implementation. This projection is based on Arkansas's population of 3.1 million, adult-use participation rates of 12-15% observed in comparable states, and average annual spending of $1,200-1,500 per consumer. The total market including medical and adult-use sales could reach $800 million annually by 2029. Tax revenue projections vary depending on the tax structure. A 10% excise tax on adult-use sales could generate $45-55 million annually, while a 15% rate could produce $67-82 million. These projections assume a mature market with stable pricing and do not account for initial implementation delays or supply constraints. Employment impacts would be significant. The medical marijuana industry currently employs approximately 2,500 Arkansans in cultivation, processing, retail, security, and testing. Adult-use legalization could add 2,000-3,000 jobs within three years, according to economic impact studies commissioned by reform advocates.

Impact on Existing License Holders

Existing medical marijuana license holders have conflicting interests regarding adult-use legalization depending on whether new licenses would be issued. The 2022 ballot measure sponsored by Responsible Growth Arkansas included provisions limiting new adult-use licenses and giving preference to existing medical operators for adult-use endorsements. This approach would have significantly increased the value of existing licenses by expanding the addressable market without proportionally increasing competition. Alternative proposals from other advocacy groups have called for a competitive licensing process open to new applicants, arguing that the existing license holders should not receive a monopoly on the adult-use market. This debate mirrors conflicts in other states including Illinois and New Jersey, where incumbent medical operators lobbied for market protections while social equity advocates and new entrepreneurs pushed for open licensing. Cultivation facilities would benefit from adult-use legalization regardless of licensing structure, as demand for wholesale cannabis would increase substantially. Existing cultivators have invested in expansion capacity in anticipation of potential legalization, with several facilities operating at 60-70% of licensed capacity as of 2026.

Real Estate and Ancillary Businesses

Real estate investors and ancillary service providers have positioned themselves for potential adult-use expansion despite regulatory uncertainty. Commercial real estate suitable for dispensaries—typically 2,000-4,000 square feet in high-traffic retail corridors—commands premium lease rates of $30-45 per square foot in Little Rock and other urban markets. Property owners have increasingly included cannabis-friendly lease terms, recognizing the industry's stability and premium rents. Ancillary businesses including security companies, testing laboratories, packaging suppliers, and compliance software providers have built operations around the medical marijuana industry. These businesses would benefit from adult-use legalization through increased transaction volume without requiring additional licenses. Testing laboratories including Green Scientific Labs and Steep Hill Arkansas have expanded capacity in anticipation of market growth. Banking and financial services remain constrained by federal prohibition. Most Arkansas cannabis businesses operate on a cash basis or with limited banking relationships through credit unions and community banks willing to accept the regulatory risk. Adult-use legalization at the state level would not resolve federal banking barriers, but increased market size could attract more financial service providers.

Impact on Black Market

Law enforcement officials and economists disagree on how adult-use legalization would affect Arkansas's illicit cannabis market. Opponents of legalization argue that Arkansas's proximity to Oklahoma's oversupplied market already creates diversion and black market activity, and that adult-use legalization would exacerbate these problems. They cite increased illegal cultivation in southern Oregon and northern California following legalization as cautionary examples. Reform advocates counter that a regulated adult-use market would reduce black market activity by providing legal access to adults who currently purchase from illicit sources. They note that medical marijuana legalization has not led to increased youth use in Arkansas, according to the Arkansas Youth Risk Behavior Survey, which showed stable or declining cannabis use rates among high school students between 2017 and 2025. Economic research from Colorado and Washington suggests that legal markets reduce but do not eliminate black market activity. Illicit markets persist due to lower prices (no taxes), access for consumers under 21, and preference for unregulated products. The extent of black market displacement depends on regulatory structure, tax rates, and enforcement priorities.

What Experts Say

Legal scholars and political scientists have characterized Arkansas's ballot initiative restrictions as among the most burdensome in the nation. According to research by the Ballot Initiative Strategy Center, Arkansas ranks 48th out of 50 states in ballot access, with only North Dakota and Wyoming imposing more restrictive requirements. The county distribution requirement is particularly unusual—only three other states impose similar geographic distribution mandates. Professor Robert Lowry, a political scientist at the University of Arkansas, has studied the state's initiative process and noted that the cumulative effect of recent legislative changes has made qualifying a measure nearly impossible without multi-million dollar budgets. According to Lowry's analysis, the cost per valid signature increased from approximately $6 in 2016 to over $13 in 2024, pricing out grassroots campaigns. Drug policy researchers have emphasized Arkansas's importance as a test case for cannabis reform in conservative Southern states. Dr. Rosalie Liccardo Pacula, a senior economist at the RAND Corporation who studies cannabis policy, has described Arkansas as representing a "second wave" of legalization states where reform must overcome both legislative resistance and procedural barriers. According to Pacula, successful legalization in Arkansas could create momentum for reform in Tennessee, Kentucky, and Alabama. Medical marijuana patients and advocates have stressed the program's benefits while arguing for expanded access. Melissa Fults, executive director of Arkansans for Cannabis Reform and a registered patient, has described how cannabis has allowed her to reduce opioid use for chronic pain management. Patient testimonials have been central to reform campaigns, with veterans, cancer patients, and parents of children with epilepsy providing compelling narratives about medical benefits. Law enforcement perspectives remain divided. The Arkansas Sheriffs' Association has opposed adult-use legalization, citing concerns about impaired driving and workplace safety. However, some individual sheriffs and police chiefs have questioned whether cannabis prohibition represents an effective use of limited law enforcement resources. Data from the Arkansas Crime Information Center shows that cannabis possession arrests have declined from over 12,000 in 2015 to approximately 6,800 in 2025, reflecting both medical marijuana legalization and changing enforcement priorities. Public health officials have emphasized the need for robust regulatory frameworks regardless of legalization status. Dr. Jennifer Dillaha, the Arkansas Department of Health's chief medical officer, has stated that any expansion of cannabis access should include strong protections against youth access, impaired driving, and public consumption. The department has recommended that any adult-use program include substantial funding for public education and prevention programs.

What's Next

The August 2026 federal court ruling striking down key ballot initiative restrictions creates a narrow window for cannabis reform advocates to qualify a measure for the 2026 general election. Judge Moody's preliminary injunction requires Arkansas to revert to pre-2021 signature-gathering rules, eliminating the county distribution requirement and relaxing canvasser restrictions. However, the injunction applies only to the 2026 election cycle pending final resolution of the lawsuit. Arkansans for Cannabis Reform announced plans to launch a signature-gathering campaign in September 2026 for a constitutional amendment legalizing adult-use cannabis. The organization must collect approximately 90,000 valid signatures by early July 2027 to qualify for the November 2027 ballot. The campaign will need to secure Attorney General approval of a ballot title, navigate potential legal challenges, and raise an estimated $1.5-2 million for signature gathering and initial campaign operations. The Arkansas Attorney General's office has indicated it will appeal Judge Moody's ruling to the Eighth Circuit Court of Appeals. The appeal could take 12-18 months to resolve, creating uncertainty about which rules will govern future initiative campaigns. If the Eighth Circuit reverses the district court's ruling, Arkansas could reinstate the restrictive requirements, potentially invalidating any signatures collected under the more permissive rules. The Arkansas legislature will convene in regular session in January 2027. Legislators could respond to the federal court ruling by enacting new ballot initiative restrictions designed to survive constitutional scrutiny, or they could choose to respect the court's decision and refrain from further restrictions. Legislative leadership has not indicated which approach they will pursue. Several scenarios could unfold over the next 18-24 months: If reform advocates successfully qualify a measure for the November 2027 ballot under the preliminary injunction rules, Arkansas voters could decide on adult-use legalization in fall 2027. Polling from Talk Business & Politics in June 2026 showed 52% of likely voters supporting legalization, 39% opposed, and 9% undecided—suggesting a competitive campaign with an uncertain outcome. If the Eighth Circuit reverses the district court and upholds Arkansas's ballot initiative restrictions, cannabis reform advocates may need to pursue alternative strategies including legislative lobbying or federal preemption. However, the Arkansas legislature has shown little appetite for cannabis reform, making a legislative path unlikely in the near term. If the federal government reschedules cannabis from Schedule I to Schedule III under the Drug Enforcement Administration's ongoing review process, the political dynamics in Arkansas could shift. Rescheduling would not legalize cannabis under federal law but would reduce federal penalties and potentially influence public opinion in conservative states. The 2026 and 2028 election cycles will also feature gubernatorial and legislative races that could reshape Arkansas's political landscape. Governor Sarah Huckabee Sanders, who has not taken a public position on cannabis legalization, will face reelection in 2026. The composition of the legislature and the positions of legislative leadership will significantly affect both ballot initiative rules and the political environment for cannabis reform.

Further Reading

• Arkansas Constitution Article 5, Section 1 (Initiative and Referendum): https://www.arkleg.state.ar.us/Bills/FTPDocument?path=%2Fconstitution%2F
• Amendment 98 (Arkansas Medical Marijuana Amendment), full text: https://www.sos.arkansas.gov/elections/past-election-results/2016/general-election-results
• Arkansas Code Annotated Title 7, Chapter 9 (Initiative and Referendum): https://advance.lexis.com/container?config=00JAA1ZDgzNzU2ZC02MDA0LTRmYWItOGFiNC02OGE2MzU3YjMzNDMKAFBvZENhdGFsb2e9zYpNUjTT6laXLCWyLBO9&crid=
• Arkansans for Cannabis Reform v. Thurston, U.S. District Court for the Eastern District of Arkansas, Case No. 4:24-cv-00342 (2026)
• Arkansas Medical Marijuana Commission meeting minutes and licensing records: https://www.